title: [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
authors.forename: G
authors.initials: G
authors.lastname: Savoye
authors.forename: O
authors.initials: O
authors.lastname: Goria
authors.forename: S
authors.initials: S
authors.lastname: Herve
authors.forename: G
authors.initials: G
authors.lastname: Riachi
authors.forename: I
authors.initials: I
authors.lastname: Noblesse
authors.forename: L
authors.initials: L
authors.lastname: Bastien
authors.forename: P
authors.initials: P
authors.lastname: Courville
authors.forename: E
authors.initials: E
authors.lastname: Lerebours
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*; D012507:Sarcoidosis / Q000139:chemically induced*; D012871:Skin Diseases / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin